HDFC Mid Cap Fund Direct Growth NAV Advances to ₹231.07 on 23 September; 3-Year CAGR Reaches 17.58%

Key Takeaways

• HDFC Mid Cap Fund Direct Growth recorded an NAV of ₹231.07 on 23 September 2026. Compared with ₹229.93 on 22 September, the NAV increased by approximately 0.50% on a calculated basis.
• The latest one-year return stood at 7.02%, whereas the three-year CAGR was substantially higher at 17.58%. That creates a 10.56 percentage-point difference between the shorter and longer return windows.
• The scheme managed approximately ₹108,325 crore, and its Direct Growth expense ratio stood at 0.74%. Minimum SIP and lump-sum investment amounts were both ₹100.
• TREPS accounted for 6.91% of the recent portfolio snapshot and was the largest disclosed allocation, but it is not an equity holding. Federal Bank was the largest listed equity position at 4.21%, followed by AU Small Finance Bank at 3.98%.

HDFC Mid Cap Fund Direct Growth NAV reached ₹231.07 on 23 September 2026. The previous exact valuation available on the individual scheme page was ₹229.93 for 22 September, giving a calculated one-day rise of approximately 0.50%. The exact-date data also placed the fund's one-year return at 7.02% and its three-year CAGR at 17.58%.

That leaves a 10.56 percentage-point gap between the latest one-year return and the annualised three-year figure. The comparison is useful primarily as a period distinction: one-year performance captures a much shorter market window, whereas the CAGR smooths the outcome across three years.

Fund size stood at roughly ₹108,325 crore. In the latest detailed scheme snapshot, the Direct Growth expense ratio was 0.74%, and the minimum SIP and lump-sum amounts were both ₹100.

The recent portfolio data also provides a different view of the scheme. TREPS accounted for 6.91% of disclosed assets, making it the largest disclosed allocation in that snapshot rather than an equity holding. Federal Bank was the largest listed equity position at 4.21%, followed by AU Small Finance Bank at 3.98%, Max Financial Services at 3.79% and Ipca Laboratories at 3.30%. Those five disclosed entries, including TREPS, totalled 22.19%.

The same snapshot reported a beta of 0.83 and a Sharpe ratio of 0.88. These are historical risk measures rather than forecasts. Taken with the NAV, returns and portfolio weights, they add context to how the fund behaved over the measurement periods used for those calculations.